Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Veracyte (VCYT) Net Margin (2016 - 2025)

Historic Net Margin for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to 14.51%.

  • Veracyte's Net Margin rose 14400.0% to 14.51% in Q3 2025 from the same period last year, while for Sep 2025 it was 6.12%, marking a year-over-year increase of 83000.0%. This contributed to the annual value of 5.41% for FY2024, which is 260200.0% up from last year.
  • Per Veracyte's latest filing, its Net Margin stood at 14.51% for Q3 2025, which was up 14400.0% from 0.75% recorded in Q2 2025.
  • Over the past 5 years, Veracyte's Net Margin peaked at 14.51% during Q3 2025, and registered a low of 114.06% during Q1 2021.
  • Over the past 5 years, Veracyte's median Net Margin value was 9.82% (recorded in 2023), while the average stood at 13.7%.
  • As far as peak fluctuations go, Veracyte's Net Margin plummeted by -764100bps in 2021, and later surged by 927200bps in 2022.
  • Quarter analysis of 5 years shows Veracyte's Net Margin stood at 15.62% in 2021, then skyrocketed by 69bps to 4.82% in 2022, then crashed by -497bps to 28.81% in 2023, then surged by 115bps to 4.33% in 2024, then skyrocketed by 235bps to 14.51% in 2025.
  • Its last three reported values are 14.51% in Q3 2025, 0.75% for Q2 2025, and 6.14% during Q1 2025.